is semaglutide a sglt2 inhibitor once weekly as add-on to SGLT-2 therapy in type 2 diabetes (SUSTAIN 9): randomised, placebo-controlled trial of latest ADA guidelines for

While it may not be drastic, researchers have found that supplementing L-carnitine can help reduce BMI, body weight, and fat mass by a modest amount

[11] and Lipsker [12] published data on melanomas different growing rates

Placebo: 2.4% weight reduction with 31.5% of participants achieving at least a 5% weight loss

If you missed, it please read it HERE

Unlike traditional treatments that target only CSF production, GLP-1 agonists may work through two pathways: Weight loss - a major long-term treatment for IIH Possible CSF pressure effects - GLP-1 receptors on the choroid plexus (where CSF is made) may reduce fluid secretion independent of weight loss The IIH Pressure Trial ( Brain , 2023) found that exenatide lowered intracranial pressure within hours of the first dose